Delivery Order SPE2DB25D3108-SPE2DB25FPCTS

Award Date 4/29/25
Potential Completion Date 4/30/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eliquis 2.5 mg tablets, a medication used to treat and prevent blood clots. The contract has a ceiling value of $5,350.72 and is a firm fixed-price delivery order, with an ultimate completion date of April 30, 2025. The contract is not set aside for any specific type of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Eliquis 2.5 mg tablets, a medication used to treat and prevent blood clots. The contract has a ceiling value of $1,965.60 and a period of performance through April 30, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with AmerisourceBergen valued at $999,999,999.00, which provides...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. The contract has a ceiling value of $9,019.05 and a period of performance through April 29, 2025. It is a firm-fixed-price contract, indicating a set price for the delivered items. The contract is not set-aside and was awarded through open...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Eliquis 5 mg tablets. The contract has a ceiling value of $4,377.73 and an ultimate completion date of April 21, 2025. The contract is a firm-fixed-price delivery order and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. The contract has a firm fixed price and a ceiling value of $23,182.59. It is not a set-aside contract, indicating open competition. The contract has an ultimate completion date of April 29, 2025 and was...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Eliquis 2.5 mg tablets. The contract has a ceiling value of $23,613.34 and a period of performance through January 8, 2025. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eliquis 2.5 mg tablet 60s, a medication used to treat and prevent blood clots. The contract has a ceiling value of $10,603.32 and is a firm fixed-price contract with an ultimate completion date of April 29, 2025. This award is not a set-aside contract, indicating open...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eliquis 2.5 mg tablets, a cardiovascular medication, with a ceiling value of $3,931.20 and an ultimate completion date of March 31, 2025. The contract is a firm fixed-price arrangement, without any set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eliquis 2.5 mg tablets, a cardiovascular medication, with a ceiling value of $3,800.16. The contract has an ultimate completion date of June 23, 2023 and is a firm fixed-price delivery order. This contract is not designated as a set-aside procurement. AmerisourceBergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. The contract has a firm fixed price of $1,584.58 and a period of performance ending on April 29, 2025. This contract is not set aside for any specific type of business. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract...
  • SPE2DB25D3108
    Indefinite Delivery Contract
  • SPE2DB25D3108-SPE2DB25FPCTS
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Eliquis 2.5 mg tablets, a medication used to treat and prevent blood clots. The contract has a ceiling value of $1,638.00 and is a firm fixed-price contract with an ultimate completion date of April 30, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order contract is likely part of the company's broader role as a critical vendor supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 7/29/25, 9:49 AM